← Company directoryNASDAQ · SEC EDGAR
Cyclerion Therapeutics, Inc.
CYCNA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Cyclerion Therapeutics CVR distribution record date
In the distribution connected with the Korsana Biosciences business combination, holders of record on 4 September will receive one contingent value right (CVR) for each CYCN share. Nasdaq will not quote the shares ex-distribution; the payment date has not been announced.
Nasdaq ↗Closing of the Cyclerion Therapeutics–Korsana Biosciences combination
The business combination and change of control between Cyclerion Therapeutics and Korsana Biosciences closed on 8 September. Nasdaq also confirmed the distribution of one CVR for each participating CYCN share held on the 4 September record date.
Nasdaq ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
CXIIChurchill Capital Corp XII - Class A Ordinary SharesNASDAQ · SEC→CXIIUChurchill Capital Corp XII - UnitsNASDAQ · SEC→CXIIWChurchill Capital Corp XII - WarrantsNASDAQ · SEC→CYABCyabra, Inc.NASDAQ · SEC→CYCUCycurion, Inc.NASDAQ · SEC→CYCUWCycurion, Inc. - WarrantsNASDAQ · SEC→CYNCyngn Inc.NASDAQ · SEC→CYPHCypherpunk Technologies Inc.NASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.